NCT01599208

Brief Summary

The goal of the proposed research is to map the effects-in particular facilitation-of Transcranial Magnetic Stimulation (TMS) of the Medial Temporal Lobes (MTL) onto the processing of associative memory. TMS technology has the potential to selectively enhance functions mediated by areas in the temporal cortex, including the MTL, known to be the primary neuronal seat of episodic memory. By using this technology the investigators can further our understanding of theoretical models of human memory (specifically regarding the role of Recollection and Familiarity processes), and additionally, provide a possible route to the recovery of some of memory loss typically observed in the elderly-namely, memory for associations. Given the MTL's critical role in human memory and facilitation-inducing qualities of TMS, this research goal is to provide a nonintrusive tool to facilitate memory performance in young and elderly healthy participants.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2012

Typical duration for early_phase_1

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 15, 2012

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2012

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

January 25, 2018

Status Verified

January 1, 2018

Enrollment Period

2.4 years

First QC Date

May 7, 2012

Last Update Submit

January 24, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in memory based on the timeframe of the online stimulation

    For the online stimulation arms, we expect to find a change in memory based on the timeframe of the online stimulation and the cognitive task, namely, we expect to find change in memory for associations when stimulation is at around 800ms, and expect a change in memory for items when stimulation is at around 400ms.

    One year

Study Arms (6)

Single-pulse online stimulation

EXPERIMENTAL

Online single-pulse online stimulation at 120% of motor threshold to either the right or left MTL, in comparison to sham condition, in either -400/0/400/800 ms relatively to stimulus in either the study or test phases of a recognition test.

Device: TMS

Repetitive online stim., 400ms, 10Hz

EXPERIMENTAL

Repetitive online stimulation for 400ms at 10Hz at 120% of motor threshold to either the right or left MTL, in comparison to sham condition, in either -400/0/400/800 ms relatively to stimulus in either the study or test phases of a recognition test.

Device: TMS

Repetitive online stim., 400ms, 20Hz

EXPERIMENTAL

Repetitive online stimulation for 400ms at 20Hz at 120% of motor threshold to either the right or left MTL, in comparison to sham condition, in either -400/0/400/800 ms relatively to stimulus in either the study or test phases of a recognition test.

Device: TMS

Repetitive offline stimulation at 10Hz

EXPERIMENTAL

Repetitive offline stimulation at 10Hz for 4 min before study or for 8 min before test (in accordance with the phase length), comprising 2-second stimulation trains and 20-second breaks. Stimulation will be given at 120% of motor threshold to either the right or the left MTL in comparison to sham condition.

Device: TMS

Repetitive offline stimulation at 20Hz

EXPERIMENTAL

Repetitive offline stimulation at 20Hz for 4 min before study or for 8 min before test (in accordance with the phase length), comprising 2-second stimulation trains and 20-second breaks. Stimulation will be given at 120% of motor threshold to either the right or the left MTL in comparison to sham condition.

Device: TMS

Repetitive offline stimulation with iTBS

EXPERIMENTAL

Repetitive offline stimulation with Intermittent Theta Burst Stimulation (iTBS) comprising 3 pulses at 50Hz, repeated at 5Hz for 2-second stimulation trains with 8-second breaks for 192 seconds. Stimulation will be given at 90% of motor threshold to either the right or the left MTL in comparison to sham condition.

Device: TMS

Interventions

TMSDEVICE

TRANSCRANIAL MAGNETIC STIMULATION

Repetitive offline stimulation at 10HzRepetitive offline stimulation at 20HzRepetitive offline stimulation with iTBSRepetitive online stim., 400ms, 10HzRepetitive online stim., 400ms, 20HzSingle-pulse online stimulation

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy men and women aged 18-85
  • Answered negatively on safety screening questionnaire for TMS
  • Capable and willing to provide informed consent.
  • For participants aged more than 65, normal memory scoring should be obtained in a Nexig test.

You may not qualify if:

  • History of epilepsy or seizure or history of such in first degree relatives.
  • Increased risk of seizure for any reason, including prior diagnosis of increased intracranial pressure, or history of significant head trauma with loss of consciousness for greater than or equal to 5 minutes.
  • History of head injury necessitating cranial surgery or prolonged coma.
  • History of any metal in the head including the eyes and ears (outside the mouth).
  • Known history of any metallic particles in the eye, implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or implanted medical pumps.
  • History of severe migraine.
  • History of significant hearing loss.
  • Individuals with a significant neurological disorder.
  • History of substance abuse including alcoholism within the past 6 months (except nicotine and caffeine)
  • Inadequate communication with the participant.
  • Participation currently in another clinical study or enrolled in another clinical study within 30 days prior to this study.
  • Participants who suffer from an unstable physical, systemic and metabolic disorders
  • Women who are breast-feeding
  • Known or suspected pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Yonatan Goshen, Prof.

    Tel Aviv University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2012

First Posted

May 15, 2012

Study Start

August 1, 2012

Primary Completion

January 1, 2015

Study Completion

June 1, 2015

Last Updated

January 25, 2018

Record last verified: 2018-01